Colleen Delaney
2023
In 2023, Colleen Delaney earned a total compensation of $360K as Chief Financial Officer at Coeptis Therapeutics Holdings.
Compensation breakdown
| Salary | $360,000 |
|---|---|
| Total | $360,000 |
Delaney received $360K in salary, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Colleen Delaney's compensation ranked 2,363rd out of 2,978 executives tracked by ExecPay. In other words, Delaney earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,363 out of 2,978 | 21st |
Division Manufacturing | 1,327 out of 1,637 | 19th |
Major group Chemicals And Allied Products | 778 out of 906 | 14th |
Industry group Drugs | 759 out of 869 | 13th |
Industry Biological Products, Except Diagnostic Substances | 193 out of 211 | 9th |
Source: SEC filing on November 14, 2024.
Delaney's colleagues
We found four more compensation records of executives who worked with Colleen Delaney at Coeptis Therapeutics Holdings in 2023.
2023
David Mehalick
Coeptis Therapeutics Holdings
Chief Executive Officer
2023
Daniel Yerace
Coeptis Therapeutics Holdings
Vice President of Operations
2023
Brian Cogley
Coeptis Therapeutics Holdings
Chief Financial Officer
2023
Christine Sheehy
Coeptis Therapeutics Holdings